ArticleInflammation2025

TXM-CB13 Improves the Intestinal Mucosal Barrier and Alleviates Colitis by Inhibiting the ROS/TXNIP/TRX/NLRP3 and TLR4/MyD88/NF-κB/NLRP3 Pathways.

Ruijie Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.